RYTM - RHYTHM PHARMACEUTICALS, INC.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 38.28

Open

$ 37.66

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 37.66 - $ 38.84

52 Week Range

$ 15.50 - $ 52.57

Volume

305,047

Average Volume

Market Cap

2.21B

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-29-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-01-2023	06-30-2023	10-Q
4	05-02-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-03-2022	06-30-2022	10-Q
8	05-03-2022	03-31-2022	10-Q
9	03-01-2022	12-31-2021	10-K
10	11-02-2021	09-30-2021	10-Q
11	08-03-2021	06-30-2021	10-Q
12	05-03-2021	03-31-2021	10-Q
13	03-01-2021	12-31-2020	10-K
14	11-02-2020	09-30-2020	10-Q
15	08-03-2020	06-30-2020	10-Q
16	05-04-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-01-2019	09-30-2019	10-Q
19	07-29-2019	06-30-2019	10-Q
20	05-03-2019	03-31-2019	10-Q
21	03-08-2019	12-31-2018	10-K
22	11-09-2018	09-30-2018	10-Q
23	08-08-2018	06-30-2018	10-Q
24	05-14-2018	03-31-2018	10-Q
25	03-12-2018	12-31-2017	10-K
26	11-14-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Analyst Expectations For Rhythm Pharmaceut...
04/26/2024 13:01:18

Needham Reiterates Buy on Rhythm Pharmaceu...
04/26/2024 10:39:34

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson

Jim Cramer Is 'Willing To Let This Pharma ...
04/19/2024 12:46:13

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

Wells Fargo Maintains Overweight on Rhythm...
04/18/2024 12:59:42

Wells Fargo analyst Derek Archila maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and lowers the price targ...

5 Analysts Assess Rhythm Pharmaceuticals: ...
04/10/2024 16:00:49

Needham Reiterates Buy on Rhythm Pharmaceu...
04/10/2024 10:26:02

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

Rhythm Pharmaceuticals Announces First Pat...
03/25/2024 12:04:49

- Three-part study to evaluate safety, tolerability and pharmacokinetics now underway -- -- RM-718 showed potential to reduce b...

Analyst Expectations For Rhythm Pharmaceut...
02/22/2024 18:00:42

Needham Reiterates Buy on Rhythm Pharmaceu...
02/22/2024 17:25:18

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

Rhythm Pharmaceuticals Announced Plans To ...
02/22/2024 12:09:24

Rhythm Pharmaceuticals Says Cash On-hand O...
02/22/2024 12:08:44

Rhythm Pharmaceuticals Q4 EPS $(0.70) Miss...
02/22/2024 12:05:50

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Preview: Rhythm Pharmaceuticals's Earnings
02/21/2024 18:01:13

Rhythm Pharmaceuticals Announces Approval ...
02/07/2024 13:25:05

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the liv...

Goldman Sachs Maintains Buy on Rhythm Phar...
01/26/2024 14:49:06

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target ...

Needham Reiterates Buy on Rhythm Pharmaceu...
01/26/2024 11:17:12

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

Rhythm Pharmaceuticals Stock: A Deep Dive ...
01/25/2024 17:00:45

Goldman Sachs Maintains Buy on Rhythm Phar...
01/25/2024 14:17:36

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target ...

The Analyst Verdict: Rhythm Pharmaceutical...
01/04/2024 16:00:57